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Objective: The emergence of extended-spectrum β-lactamase (ESBL)-producing
bacteria is now a critical concern. The ESBL-producing Klebsiella pneumoniae
constitutes one of the most common multidrug-resistant (MDR) groups of gram-negative
bacteria involved in nosocomial infections worldwide. In this study we report on the
molecular characterization through whole genome sequencing of an ESBL-producing
K. pneumoniae strain, LAU-KP1, isolated from a stool sample from a patient admitted
for a gastrointestinal procedure/surgery at the Lebanese Amrican University Medical
Center-Rizk Hospital (LAUMCRH) in Lebanon.
Methods: Illumina paired-end libraries were prepared and sequenced, which resulted in
4,220,969 high-quality reads. All sequence processing and assembly were performed
using the A5 assembly pipeline.
Results: The initial assembly produced 86 contigs, for which no scaffolding was
obtained. The final collection of contigs was submitted to GenBank. The final
draft genome sequence consists of a combined 5,632,663 bases with 57% G+C
content. Automated annotation was performed using the RAST annotation server.
Sequencing analysis revealed that the isolate harbored different β-lactamase genes,
including blaoxa−1, blaCTX−M−15, blaSHV−11, and blaTEM−1b. The isolate was also
characterized by the concomitant presence of other resistance determinants most
notably acc(6′)-lb-cr and qnrb1. The entire plasmid content was also investigated and
revealed homology with four major plasmids pKPN-IT, pBS512_2, pRSF1010_SL1344,
and pKPN3.
Conclusions: The potential role of K. pneumonia as a reservoir for ESBL genes and
other resistance determinants is along with the presence of key factors that favor
the spread of antimicrobial resistance a clear cause of concern and the problem
that Carbapenem-non-susceptible ESBL isolates are posing in hospitals should be
reconsidered through systematic exploration and molecular characterization.
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Introduction
Extended-spectrum β-lactamases (ESBL) are enzymes produced
by many bacterial species as a means for defense against β-lactam
drugs with the genes encoding for those enzymes being mainly
located on mobile genetic elements (Pfeifer et al., 2010). ESBL
enzymes confer antimicrobial resistance to a wide spectrum of
β-lactams such as penicillins, aztreonam, as well as first, second,
and third generation cephalosporins (Jacoby andMedeiros, 1991;
Bradford, 2001). β-lactamases are widespread and were detected
in a wide range of Enterobacteriaceae (Bradford, 2001) predomi-
nantly in Escherichia coli, and Klebsiella pneumoniae, as well as in
other non-enteric microorganisms, such as Pseudomonas aerug-
inosa, Acinetobacter baumanni (Naas et al., 1999; Spanu et al.,
2002; Goossens and Grabein, 2005; Paterson and Bonomo, 2005),
and Capnocytophaga ochracea (Rosenau et al., 2000). In addition,
Shigella species have been increasingly reported to be resistant to
β-lactams including third-generation cephalosporins (Levesque
et al., 1995).
K. pneumoniae is an important human pathogen causing
nosocomial infections (Podschun and Ullmann, 1998). ESBL-
producingK. pneumoniae is one of the most commonmultidrug-
resistant (MDR) groups of gram-negative bacteria worldwide
(Breurec et al., 2013). Infections caused by ESBL-producing
K. pneumoniae are often associated with the urinary and res-
piratory tracts along with epidemic clones causing outbreaks in
intensive care units (Peirana et al., 2012).
There are four molecular classes of β-lactamases. Classes A,
C, and D. β-lactamases possess an active-site serine, while class
B β-lactamases are metalloenzymes requiring Zn molecule for
their activity (Ambler et al., 1991; Bush et al., 1995). CTX-M
is a dominant ESBL family in K. pneumoniae strains, but TEM
and SHV enzymes in addition to members of the three classes
of β-lactamases (B, C, D) are also common (Breurec et al.,
2013). Carbapenems are usually used for the treatment of infec-
tions caused by ESBL producing Enterobacteriaceae. Increasing
rates of ESBL-producing isolates has led to the overuse of car-
bapenems creating a pressure and triggering resistance. Resis-
tance to carbapenems may be associated with the production
of carbapenemases including class A KPCs, class B metallo-β-
lactamases (VIM, IMP, or NDM-1) or the class D OXA-type
enzymes (Queenan and Bush, 2007;Matar et al., 2008; Nordmann
et al., 2009).
The aim of this study is to characterize an ESBL-producing
K. pneumoniae isolated from a stool sample from a patient
admitted for a gastrointestinal procedure/surgery in a Lebanese
hospital using whole genome sequencing (WGS).
Materials and Methods
Ethical Approval
The University’s Institutional Review Board approved the study
(UMCRH.AF.12/Dec/2012).
Study Design and Bacterial Isolate
Samples were collected from the University Medical Center-Rizk
Hospital (UMC-RH). All patients included in the study were
screened for the presence of ESBL-producing Enterobacteriaceae
by means of three consecutive rectal swab or stool cultures, as per
regular screening for ESBL detection. The first fecal sample was
collected at the same time as the other preoperative tests. The
second and third samples were collected later, latest day 2-post
surgery. K. pneumoniae LAU-KP1 sequenced in this study was
isolated from a 62-year-old woman working as practitioner nurse
or nurse’s assistant. She was admitted for radical resection of an
abdominal tumor and repair of abdominal hernia. The patient
had other than her cancer, recurrent urinary tract infections. She
had been using amoxicillin-clavulanate, metronidazol, and cefri-
axon in the 3 months prior to presentation. She had been admit-
ted to hospital in the year prior to surgery, but was not known
to be a carrier of multidrug resistant organism and no one in
her household was known to be a carrier of multidrug resistant
organisms.
Screening for ESBL
The standard disk diffusion method with combined discs (cef-
tazidime/clavulanate and cefotaxime/clavulanate) was used for
screening. The standard E-test method using double sided strips
containing on one side ceftazidime or cefotaxime and on the
other the same antibiotic combined with clavulanate was used
to assess for screening and confirming ESBL production in all
strains according to the recommendations of the CLSI. E. coli
ATCC25922 and K. pneumoniae ATCC700603 were used as the
quality control strains.
Antimicrobial Testing
Antimicrobial susceptibility test by the disk diffusionmethod was
performed to determine the resistance patterns of the isolates to
17 antibiotics: cefotaxime, ceftriaxone, ceftazidime, aztreonam,
ceftazidime/clavulanate, cefotaxime/clavulanate, cephalothin,
cefuroxime sodium, cefepime, gentamicin, amikacin,
ciprofloxacin, tetracycline, ampicillin, amoxicillin/clavulanate,
piperacillin, piperacillin/tazobactam, imipenem, meropenem,
ertapenem, and sulfamethoxazole/trimethoprim [Oxoid, Eng-
land; disc contents according to Clinical and Laboratory
Standards Institute (CLSI) guidelines]. All antimicrobial test-
ing was performed on Mueller-Hinton agar by the flooding
technique and data interpreted according to the CLSI guidelines.
DNA Isolation and Sequencing
Bacterial DNA was extracted using the Nucleospin kit
(Macherey-Nagel) and following the manufacturer’s instructions.
Genome Sequencing
Genomic DNA (gDNA) was used as input for library prepa-
ration using the Illumina TruSeq DNA library preparation kit
(Illumina). Bioruptor R© NGS was used to sonicate 1µg of sam-
ple DNA (100µl final sonication volume in TE buffer) for 8min
of 30 s on/off cycles at 4◦C. Sheared DNA was used as input
for library preparation using the Illumina TruSeq DNA library
preparation kit (Illumina). The gDNA was subjected to end-
repair, A-tailing, ligation of adaptors including sample-specific
barcodes as recommended in the manufacturer’s protocol. After
ligation of the adaptors, and to reduce the number of fragments
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 April 2015 | Volume 5 | Article 32
Tokajian et al. Extended-spectrum β-lactamase producing Klebsiella pneumoniae
smaller than 500 bp, fragments between 500 and 1000 bp were
selected using a Pippin Prep™ DNA size selection system (Sage
Science). The resulting library was quantified by quantitative
PCR in triplicate at 1:1000 and using the Kapa library quantifica-
tion kit (Kapa Biosystems, Woburn, MA) and as recommended
by the manufacturer’s protocol. The resultant library size was
assessed using an Agilent Bioanalyzer with the High Sensitivity
DNA Kit. The library was multiplexed, clustered, and sequenced
on an IlluminaMiSeq with paired-end 500 cycles protocol to read
a length of 250 bp.
Genome Assembly
Genome assembly was performed de novo using A5 with default
parameters (Tritt et al., 2012). This pipeline automates the pro-
cesses of data cleaning, error correction, contig assembly, scaf-
folding and quality control.
Genome Analysis
The assembly was uploaded and annotated using RAST server
(http://rast.nmpdr.org). The service identified protein-encoding,
rRNA and tRNA genes, assigned functions to the genes, and pre-
dicted which subsystems are represented in the genome (Larsen
et al., 2012).
The multi-locus sequence type for the isolate was deter-
mined from the WGS data. The presence of known acquired
resistance genes was determined by mapping the data from
the isolate to an online database. The ResFinder web server
(www.genomicepidemiology.org) was used to identify acquired
antimicrobial resistance genes in the WGS data, using a thresh-
old of 98.00% identity (ID) (Zankari et al., 2012). ResFinder
detects the presence of whole resistance genes, but not func-
tional integrity and expression or resistance due to acquired vari-
ation in housekeeping genes. Based on the ResFinder results,
a predicted phenotype was determined using phenotypes from
original published studies of the genes found.
A K. pneumoniae concatenated marker gene maximum-
likelihood tree was constructed using all available assembled
K. pneumoniae genomes on the NCBI ftp server. The genomes
were first processed with PhyloSift (Darling et al., 2014) using
–besthit and –isolate options to get alignments to concatenated
conserved housekeeping genes. The tree was made using Fast-
Tree (Price et al., 2010). The tree was edited and visualized using
Dendroscope (Huson and Scornavacca, 2012). Clades with zero
branch lengths were collapsed to a single representative. For
visualization of LAU-KP1, the assembly was aligned against the
reference strain K. pneumoniae Ecl8’s (GCF_000315385) using
progressiveMauve (Darling et al., 2010). Ring representation was
obtained using BRIG 0.95 (Alikhan et al., 2011). Ecl8 is the
K. pneumoniae isolate which was closest to LAU-KP1 in the
concatenated marker gene tree that had a complete genome.
Nucleotide Sequence Accession Number
The draft sequence of the K. pneumoniae LAU-KP1 have been
deposited at DDBJ/EMBL/GenBank under the accession no.
AYQE00000000.1.
Results and Discussion
To the best of our knowledge we report for the first time the
isolation of a CTX-M-15, SHV-11, KPC-producing K. pneumo-
niae belonging to ST336 in Lebanon. This clone belongs to CG17
and was isolated from a 62-year-old woman working as prac-
titioner nurse or nurse’s assistant. She was admitted for radical
resection of an abdominal tumor and repair of abdominal her-
nia. The patient had other than her cancer, recurrent urinary tract
infections.
In K. pneumoniaeMLST is based on genetic variation in seven
housekeeping genes (rpoB, gapA, mdh, pgi, phoE, infB, and tonB)
(Diancourt et al., 2005). ST allele profile of ST336 is: 2-1-1-1-
72-4-4, while ST258, being the most common KPC-producing
isolate (Woodford et al., 2011), is: 3-3-1-1-1-1-79 (http://www.
pasteur.fr/mlst). Screening patients for rectal carriage by Bara-
niak et al. (2013) revealed the prevalence of CG17 in France,
highlighting the role of human mobility in spreading MDR K.
pneumoniae clones.
LAU-KP1 was found to be resistant to the following drugs:
ciprofloxacin, cefotaxime, aztreonam, and ceftazidime. It was
intermediate to amoxicillin clavulanic acid, and sensitive to
imipenem and gentamycin. Analysis of the data extracted from
the draft genome sequence however, revealed that LAU-KP1 was
characterized by the presence of multiple resistance determi-
nants, most notably was the concomitant presence of acc(6′)lb-cr,
qnr, SHV-11, and CTX-M-15. CTX-M-15 detection was consis-
tent with the recent predominance of CTX-M and CTX-M-15 in
particular (Rossolini et al., 2008), which additionally was found to
be more common in K. pneumoniae than in E. coli in rehabilita-
tion units (Baraniak et al., 2013). Rodrigues et al. (2014) reported
recently that the increase in the incidence of CTX-M-15 and
diverse SHV ESBL types observed in a Portuguese hospital was
associated with the increase of MDR K. pneumoniae epidemic
clones (ST15, ST147, ST336). Harbouring the qnrB1 (quinolone
resistance) was another important finding that additionally dis-
tinguished LAU-KP1. Previously Breurec et al. (2013) revealed
that qnrBwas predominant among strains fromAfrica while qnrS
was mainly detected in strains from Vietnam.
Resistance to carbapenems involves multiple mechanisms
including alterations in outer membrane permeability medi-
ated by the loss of porins, upregulation of eﬄux systems along
with hyper production of AmpC β-lactamases or more com-
monly the production of carbapenemases (Chen et al., 2014).
Class A carbapenemases include the K. pneumoniae carbapen-
emase (KPC). These enzymes hydrolyze all β-lactams includ-
ing monobactams (El-Herte et al., 2012). Carbapenem resistant
Enterobacteriaceae have spread inNortheasternUSA and to other
countries including Argentina, Greece, Italy, and China (Nord-
mann and Poirel, 2014). Transmission of the KPC gene can be
mediated through horizontal gene transfer on mobile elements
including transposons and plasmids (Munoz-Price and Quinn,
2009). Spread of the KPC-producing K. pneumonia has been
linked to a major multi locus sequence type (MLST-ST) ST258
and its variants (Cuzon et al., 2010; Chen et al., 2014). LAU-KP1
harbored INCFIIK plasmids and DNA comparison showed the
presence of sequences with high homology to plasmid pKPN-IT
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FIGURE 1 | Phylogenetic tree of all assembled K. pneumoniae
genomes available on the NCBI ftp server as of 2-11-15, based on a
concatenated alignment of 37 conserved genes obtained using
PhyloSift (Darling et al., 2014). The tree was constructed using default
(Continued)
FIGURE 1 | Continued
settings in FastTree (Price et al., 2010) and edited and visualized with
Dendroscope v.3 (Huson and Scornavacca, 2012). Clades with zero branch
lengths were collapsed to a single representative. K. pneumoniae LAU-KP1 is
indicated by a square, and the reference genome used in Figure 2 is indicated
by a diamond.
and pKPN3. This was consistent with the finding that the dis-
semination of CTX-M-15 was primarily associated with IncFIIK
plasmid in K. pneumoniae isolates (Coelhoa et al., 2010). Earlier
Garcia-Fernandez et al. (2012) detected in K. pneumoniae ST258
IncFIIK-FIB like plasmid and was named as pKPN-IT. This plas-
mid was highly related to plasmid pKPN3. The plasmid pKPN-IT
was shown to also acquire Fec-like iron (III) dicitrate transport
system and a class I integron carrying trimethoprim resistance,
both of which were also detected in LAU-KP1.
β-lactamase class C, the presence of which renders bacteria to
become resistant to most β-lactams including cephamycins and
β-lactam/β-lactamase combinations (Doi and Paterson, 2007)
was and along with macrolide-specific eﬄux pump MacAB-
TolC important factors increasing the resistance of LAU-KP1.
Periplasmicmembrane fusion proteins (MFPs) are essential com-
ponents of the type I protein secretion systems and drug eﬄux
pumps in Gram-negative bacteria (Tikhonova et al., 2007). MacA
is a peripheral membrane protein of the MFP family and a
component of the MacAB macrolide eﬄux transporter complex.
MacB on the other hand, is an integral membrane protein. Sim-
ilar to other MFP-dependent transporters from E. coli, MacAB
requires the outer membrane channel TolC for its function
(Kobayashi et al., 2001; Tikhonova et al., 2007).
Additionally, a key feature of these MDR eﬄux systems is
their ability to extrude a broad spectrum of substrates, includ-
ing various antimicrobial agents (Bambeke et al., 2000; Put-
man et al., 2000; Poole, 2001). One important family of drug
transporters that contribute to multidrug resistance (MDR) in
gram-negative bacteria are the resistance-nodulation-cell divi-
sion (RND) eﬄux systems, which consist of an inner membrane
transporter, a periplasmic fusion protein, and an outer mem-
brane protein (Zgurskaya and Nikaido, 2000). Detecting Cme-
ABC operon in LAU-KP1 was an important feature. CmeABC
is an energy-dependent eﬄux system contributing to the intrin-
sic resistance of Campylobacter to diverse antimicrobial agents.
Disruption of the CmeABC resulted in MICs that were 8-fold
lower for ciprofloxacin, 2-fold for norfloxacin and nalidixic acid,
256-fold for cefotaxime, and 32-fold for ampicillin (Lin et al.,
2002).
In K. pneumoniaeMLST is based on genetic variation in seven
housekeeping genes (rpoB, gapA, mdh, pgi, phoE, infB, and tonB)
(Diancourt et al., 2005). ST allele profile of ST336 is: 2-1-1-1-
72-4-4, while ST258, being the most common KPC-producing
isolate (Woodford et al., 2011), is: 3-3-1-1-1-1-79 (http://www.
pasteur.fr/mlst). Screening patients for rectal carriage by Bara-
niak et al. (2013) revealed the prevalence of CG17 in France,
highlighting the role of human mobility in spreading MDR
K. pneumoniae clones.
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FIGURE 2 | K. pneumoniae LAU-KP1 ring representation using BRIG
0.95 (Alikhan et al., 2011). The contigs from LAU-KP1 were ordered to
match Ecl8’s (GCF_000315385) genomic arrangement using
progressiveMauve (Darling et al., 2010). Ecl8 is the K. pneumoniae isolate
which was closest to LAU-KP1 in the tree shown in Figure 1 for which there
was a finished genome available. The inner ring shows the percent identity
comparing Ecl8 and LAU-KP1. The next ring alternating blue and red
sections shows the contig delimitations for LAU-KP1. The next ring shows
the location of tRNAs according to Prokka v1.7 (Seemann, 2014). The last
two (outer) rings show the GC content and skew.
Furthermore, the phylogenetic analysis of LAU-KP1 showed
that it falls within a clade of other known multidrug resistant
K. pneumoniae strains and demonstrated that there is consider-
able genomic diversity among the included isolates (Figure 1).
Within the closely related isolates was K. pneumonia 7699 pre-
viously cultured from a perianal swab of a patient admitted to the
intensive care unit of the University of Maryland Medical Cen-
ter (UMMC) in Baltimore, MD (Hazen et al., 2014). The isolate
had a 167-kb IncA/C plasmid encoding the FOX-5 β-lactamase, a
CARB-2 β-lactamase, other antimicrobial resistance genes, and
heavy metal resistance genes. On the other hand, a consid-
erable phylogenetic difference was detected between LAU-Kp1
and K. pneumoniae ATCC BAA-2146, which is the first U.S.
isolate found encoding the gene for the broad-spectrum and
carbapenem-active metallo-β-lactamase NDM-1 (Hudson et al.,
2014). Additionally, we mapped our contigs to the phylogeneti-
cally closest K. pneumoniae isolate with a complete genome, Ecl8,
in order to visualize the genomic organization (Figure 2).
The detection of such a multidrug resistant strain of K.
pneumoniae emphasizes the potential for transmission of highly
resistant gram-negative pathogens that are difficult to treat.
This merits more detailed future studies directed toward
characterization of molecular mechanisms, environmental fac-
tors, and selection pressures promoting the spread of such strains.
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Detection of IncFIIK a virulence plasmid (Dolejska et al., 2013)
known to evolve quickly by replicon diversification and acqui-
sition of antibiotic resistance traits (Coelhoa et al., 2010; Carat-
toli, 2013), increases the potential role of K. pneumoniae as
a reservoir for ESBL genes and other resistance determinants.
The spread of antimicrobial resistance in this region could be
attributed to different factors including: uncontrolled consump-
tion of antimicrobial agents through self-medication, inappro-
priate antibiotic prescription, the substandard quality of some
drugs, and a lack of effective measures to prevent nosocomial
infections. The virtual lack of physical barriers between the com-
munity and hospital settings in the countries in this region
and the increasing pressure from war immigrants along with
poor living conditions may be also important contributory fac-
tors. High-resolution genotyping studies of isolates collected over
larger spatial and temporal scales will be necessary to decipher
the dynamics of the emergence of MDR K. pneumoniae clonal
groups.
Therefore, we urgently need well-designed epidemiological
and molecular studies to understand the dynamics of transmis-
sion, risk factors, and reservoirs for K. pneumoniae. This will
provide a better insight into the emergence and spread of these
multidrug resistant strains and hopefully lead to information
essential in preventing infections and limiting the spread of such
organisms.
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